An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study
Open accessPublished version of a preprint
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; 22 of the 64 sources its claims cite were checked for support.
Abstract
Background: In sub-Saharan Africa, the disease burden from skin diseases, including skin-related neglected tropical diseases (skin NTDs), is extremely high. These diseases often are overlooked due to limited access to health care stemming from, for example, remote geographical locations and a lack of experts. To address these gaps, we developed a mobile health app, eSkinHealth, which is a field-adapted platform to serve as a portable electronic patient chart and for teledermatology. Objective: The purpose of the study is to evaluate the usability and effectiveness of the app in rural Côte d’Ivoire for diagnosing and managing skin NTDs and other skin diseases. Methods: A 2-arm trial with local health care providers and patients with skin diseases was implemented over a 3-month period. The providers were assigned to an intervention receiving the eSkinHealth app or control with usual care. Four nurses and 8 community health care workers participated in each arm. The training was provided on the use of the app to the intervention arm only, while both arms were trained on skin diseases. For the usability study, we evaluated our approach with the System Usability Scale (SUS) and in-depth interviews. For the effectiveness study, our primary outcome was to evaluate the detection and management of 5 skin NTDs as our targeted diseases, namely, Buruli ulcer, leprosy, lymphatic filariasis, scabies, and yaws, using the eSkinHealth app. Procedures of our methods were reviewed and approved by the institutional review board of the Ministry of Health and by Tulane University. Results: The mean age of our participants (providers) was 40.5 and 42.5 years for the intervention and control arms, respectively, and all were male (n=24). The average SUS scores taken from the intervention arm at baseline, the midpoint (6 weeks), and the end of study (12 weeks) were 72.3 (SD 11.5), 72.3 (SD 12.4), and 86.3 (SD 10.8), respectively. All participants interviewed, including 4 dermatologists and program managers, were satisfied with the app. Especially community health care workers felt empowered by being equipped with the tool. A total of 79 cases of skin NTDs were reported in the intervention arm as compared to 17 cases in the control arm (P=.002). Besides the skin NTDs, more skin diseases and conditions were reported from the control than from the intervention arm (P<.001). However, 100 cases (66%) were not given any particular diagnosis in the control arm and were documented only as a “dermatosis.” In the intervention arm, 151 cases (72.9%) were diagnosed within the eSkinHealth platform, and the remaining were diagnosed on-site by dermatologists. Conclusions: The study provided evidence for the usability and effectiveness of the eSkinHealth app embedded into our surveillance approach to improve the detection and management of skin NTDs and other skin diseases in Côte d’Ivoire and, furthermore, is expected to contribute to knowledge on mobile health approaches in the control of skin diseases in resource-limited settings. Trial Registration: ClinicalTrials.gov NCT05300399; https://clinicaltrials.gov/ct2/show/NCT05300399
Overview
CoChat Summary
TL;DR
This 3-month, 2-arm mixed methods pilot in rural Côte d’Ivoire evaluated the eSkinHealth mHealth app for detecting and managing skin-related neglected tropical diseases (skin NTDs) and other skin diseases. The app showed high usability and was associated with more skin NTD cases detected in the intervention arm than in the control arm, although poor connectivity and incomplete control-arm data limited effectiveness assessment.
Key findings
- Mean System Usability Scale scores in the intervention arm were 72.3 (SD 11.5) at baseline, 72.3 (SD 12.4) at 6 weeks, and 86.3 (SD 10.8) at 12 weeks.
- A total of 79 skin NTD cases were reported in the intervention arm versus 17 in the control arm (P=.002).
- In the intervention arm, 151 cases (72.9%) were diagnosed within the eSkinHealth platform, with the remainder diagnosed on-site by dermatologists; in the control arm, 100 cases (66%) were documented only as “dermatosis.”
- All interviewed participants, including 4 dermatologists and program managers, were satisfied with the app; community health care workers reported feeling empowered by the tool.
Methods
- A 2-arm pilot trial was conducted over 3 months in 8 primary health centers in Sinfra Health District, Côte d’Ivoire; 4 nurses and 8 community health care workers participated in each arm, and patients with skin conditions were enrolled.
- The intervention arm used the eSkinHealth app for diagnosis and management, while the control arm received usual care; both arms were trained on skin diseases, including 5 target skin NTDs: Buruli ulcer, leprosy, lymphatic filariasis, scabies, and yaws.
- Usability was assessed with the System Usability Scale at baseline, 6 weeks, and 12 weeks plus in-depth interviews; effectiveness compared numbers of cases diagnosed and followed up between arms, with statistical analysis in Stata v16 and qualitative coding in MAXqda.
Limitations
- The paper states that poor internet connectivity affected results and hindered assessment of true effectiveness; monitoring visits may have contributed to observed benefits; all participants were male; and findings from 8 primary health centers in 1 health district may not be generalizable.
- The paper also states that control-arm data were inadequate for valid comparison because participants did not organize photographs with patient information as instructed, and follow-up was limited, with only 18.3% of intervention patients having more than one follow-up.
- Evident from the text: the study did not measure time required to register each patient, and the low follow-up rate may indicate the follow-up function was not well understood or was affected by patients not returning.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
10 Valid · 1 Not valid · 20 Not checked · 126 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, some diseases, including leprosy, Buruli ulcer, lymphatic filariasis, and other skin infections, lead to lifelong disabilities and deformities if not diagnosed and treated early [10,12].”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Introduction
What the sources say
- Supportedcites [10] source
The Introduction states that several NTDs with cutaneous manifestations are 'associated with long-term disfigurement and disability, including Buruli ulcer (BU); cutaneous leishmaniasis (CL); leprosy; mycetoma; yaws; hydrocele and lymphoedema (resulting from lymphatic filariasis)', covering every disease the claim names plus other skin conditions. The Treatment section closes the loop with the conditional the claim attributes: 'If skin NTDs are diagnosed and treated early, disabilities and disfigurements are preventable.' Table 1 (Burden of Skin NTDs) corroborates permanence for the specific diseases — 'Severe scarring with limb contractures' (BU), 'Peripheral neuropathy and permanent damage of the limbs, eyes and nose' (leprosy), 'Lymphoedema and elephantiasis' (filarial lymphoedema). (LLM, conf=0.90)
- Supportedcites [12] source
The Abstract (p. 1) states that with these diseases, 'which include leprosy, Buruli ulcer, yaws, mycetoma, lymphatic filariasis, and leishmaniasis, patients may be left with life-long deformities and disabilities when diagnosis and treatment are delayed,' and Section 6 repeats it with the same disease list ('Buruli ulcer, leprosy, tropical ulcers, lymphatic filariasis, podoconiosis, etc.') adding that 'Early identification and treatment can reduce this.' The named diseases, the outcome (lifelong disabilities/deformities) and the conditional on early diagnosis and treatment are all carried by our copy; the only difference is wording of certainty ('may/can lead' versus 'lead'), with the contingency preserved by the claim's 'if not diagnosed and treated early'. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A few attempts at teledermatology have been made in sub-Saharan African countries and have shown promising results [17-19].”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Introduction
What the sources say
- Supportedcites [17] source
Our copy is itself an attempt at teledermatology in a sub-Saharan African country: the Abstract reports a store-and-forward pilot in 10 primary centres in Mali in which 96% of 180 patients were properly managed and the initiative 'hugely improved the management of all skin diseases', and the Conclusions state the programme 'is feasible and can positively impact the management of skin disorders' in resource-limited countries. The Discussion (p. 4) also supports the 'a few attempts' framing, noting that the greatest number of published studies were in the US, UK, Spain, the Netherlands, Italy and Austria and that 'very few studies were conducted in Africa'. As an identifying/exemplifying citation this source is what the citing sentence attributes it to be. (LLM, conf=0.85)
- Not checked yetcites [18] source
- Partly supportedcites [19] sourceExperimental — accuracy not yet measured
The Introduction (p.1) states that teledermatology has been used for some years, that "numerous studies have been published describing the potential of teledermatology in low-income settings" and that "although trials seem to confirm they are effective, they show some limitations", and the Principal Findings endorse store-and-forward teledermatology as "an ideal approach to assess skin lesions" — so the "promising results" element is present, but for low-income/resource-poor settings generally, not confined to sub-Saharan Africa. Our copy contains no passage attributing teledermatology attempts specifically to sub-Saharan African countries; the sub-Saharan African studies it includes (SkinApp in Nigeria and Mozambique, WhatsApp supervision in Tanzania, Measure SMS-morbidity in Ethiopia/Malawi/Ghana) are mHealth apps, SMS and decision-support interventions rather than teledermatology trials. The claim also states the results as fact, where the source hedges ("seem to confirm", with caveats on dermatologist availability and internet connection). (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Currently, teledermatology is mostly done on platforms without any formal framework for the collection or organization of data [19,25].”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Introduction
What the sources say
- Could not verifycites [19] sourceExperimental — accuracy not yet measured
Our copy of Carrion et al. (2020, JMIR mHealth uHealth) discusses teledermatology only in terms of its effectiveness and its limitations — the Introduction states interventions 'are not yet scaled up' and show limitations 'such as the need for both a dermatologist available on demand and a stable and strong internet connection', and the Principal Findings describe store-and-forward teledermatology as an ideal approach for assessing skin lesions. No passage says teledermatology is mostly practised on platforms lacking a formal framework for the collection or organization of data. Searched: 'formal framework for data collection/organization', 'standardized data collection', 'limitations of teledermatology platforms', 'data recording surveillance'; the closest material is Table 2 (Challenges: data accuracy, data ownership, image and data quality, HCP perceptions about digital data collection), which refers to mHealth tools for skin NTDs generally rather than to teledermatology platforms' data framework. (LLM, conf=0.65)
- Not checked yetcites [25] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Poor or no connection to network services has been one of the major challenges shared across projects aiming at implementing mHealth strategies in LMICs [19,41,42].”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Discussion > Principal Findings
What the sources say
- Supportedcites [19] source
The ‘Elements Included in the mHealth Interventions’ section identifies poor network coverage and no internet connection as main technological issues. The table in ‘Conclusions’ lists connectivity problems for several of the reviewed projects; page numbers are not provided in our copy. (LLM, conf=0.90)
- Partly supportedcites [41] sourceExperimental — accuracy not yet measured
The Results identify lack of infrastructure as the most frequent barrier category, and the Discussion’s Recommendations mention mobile network fluctuations as a problem for mHealth interventions (page numbers unavailable). The review does not establish that poor or absent network connections specifically were a major challenge shared across projects. (LLM, conf=0.82)
- Supportedcites [42] source
The Results (Review findings; page not provided) identify poor network connectivity as one of the most cited challenges for health workers using mobile devices and say it impeded interventions. The Results (Description of the included studies; page not provided) report that 32 of the 43 sampled studies were conducted in low- or middle-income countries. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A total of 79 cases of skin NTDs were reported in the intervention arm as compared to 17 cases in the control arm (P=.002).”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Abstract > Results
plainstates an associationn = 79 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
43 more claims
Create a free account to see all 157 claims and to verify the 42 references still open.
- It may state two separate claims as one. 65
- Probably not a substantial claim. 72
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Six studies sought to evaluate the applicability of remote telediagnosis of clinical conditions related to NTD [14,15,17,18,20,21], but only three of them compared the effectiveness/accuracy of remote diagnosis via telemedicine with in-person medical care as a gold standard [14,20,21].”
From Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increase on diagnostic and treatment capacity of skin NTDs in communities was also observed in two studies [15,17] in which specialist physicians assessed and followed via telemedicine cases of leprosy, Buruli ulcer, yaws, leishmaniasis, scabies, and tungiasis.”
From Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Henceforth, the use of mobile applications for remote care for NTDs emerges as a promising resource [16,17,21].”
From Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“four studies (N=4) were focused on dermatological diseases [14,15,16,17]: one specifically on leprosy [14] (N=1), one specifically on leishmaniasis [16] (N=1), and two in general dermatological diseases [15,17].”
From Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review (2025) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Four studies were developed at least one of the arms in remote and/or rural areas [2,15–17], three in urban settings [14,18,19] and in one it was not described [20].”
From Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review (2025) · cites this paper as [17]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| With diagnosis or condition, %a | 98.4 | 66.0 | 74.6 |”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Results
Reported 74.6 · recomputed 75.829384
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Discussion > Principal Findings
“While our SUS scores were rated “excellent” for all 3 time points, they significantly increased during the intervention, jumping from a mean of 72.3 both at baseline and week 6 to 86.3 at the end of the project.”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Methods > Outcome Measurement
“In addition, a SUS score above 80 is considered excellent and places the product in the top 10% of products tested [35].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Abstract > Trial Registration
“ClinicalTrials.gov NCT05300399; https://clinicaltrials.gov/ct2/show/NCT05300399”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Methods > Ethics Approval
“This study is registered at ClinicalTrials.gov (2020-2054).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Discussion > Principal Findings
“only a limited proportion of patients (18.3%) had more than one follow-up.”
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Results
“In the intervention arm, 24 of 207 patients (11.6%) had 1 follow-up (this excludes the first visit), 11 patients (5.3%) had 2 follow-ups, and 3 patients (1.4%) had 3 follow-ups entered by the nurses.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“However, 100 cases (66%) were not given any particular diagnosis or description of a condition in the control arm and were documented only as a “dermatosis.””
§ An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study > Results
Reported 66 · recomputed 34.013605
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
An Empirical Evaluation of the System Usability Scale
Bangor, A., Kortum, P. T., & Miller, J. T. (2008) · International Journal of Human–Computer Interaction · doi:10.1080/10447310802205776 · Cited by 5,181 · cited 1×
“91) and useful over a wide range of interface types [33,34].”
BackgroundUsability Evaluation In Industry
(1996) · CRC Press eBooks · doi:10.1201/9781498710411 · Cited by 4,354
Michie, S., Yardley, L., West, R., Patrick, K., & Greaves, F. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7126 · Cited by 865 · cited 1×
“We do not necessarily consider this to be overly long, as the usage of the app involves a behavioral change in their daily practice, and usually behavioral change takes time [36].”
BackgroundMethods of usability testing in the development of eHealth applications: A scoping review
Maramba, I., Chatterjee, A., & Newman, C. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.03.018 · Cited by 602 · cited 1×
“We then applied a questionnaire survey to investigate the usability of the eSkinHealth app [29].”
MethodDetermining what individual SUS scores mean
(2009) · Journal of Usability Studies archive · doi:10.5555/2835587.2835589 · Cited by 412
Kruse, C., Betancourt, J., Ortiz, S., Valdes Luna, S. M., Bamrah, I. K., & Segovia, N. (2019) · Journal of Medical Internet Research · doi:10.2196/13263 · Cited by 299 · cited 17×
“The health system built upon this approach is also expected to benefit not only skin NTDs but other skin diseases that are prevalent in LMICs [13,14].”
BackgroundInfluentialOdendaal, W. A., Anstey Watkins, J., Leon, N., Goudge, J., Griffiths, F., Tomlinson, M., & Daniels, K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011942.pub2 · Cited by 289 · cited 19×
“The health system built upon this approach is also expected to benefit not only skin NTDs but other skin diseases that are prevalent in LMICs [13,14].”
BackgroundResultInfluentialMobile Health (mHealth) in Low- and Middle-Income Countries
McCool, J., Dobson, R., Whittaker, R., & Paton, C. (2022) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-052620-093850 · Cited by 269 · cited 2×
“There is potential for mHealth tools and telemedicine systems to fill this gap [40].”
BackgroundA Review of Scabies: An Infestation More than Skin Deep
Chandler, D. J., & Fuller, L. C. (2019) · Dermatology · doi:10.1159/000495290 · Cited by 259 · cited 1×
“However, if left untreated, even some of the most common skin diseases could have severe complications (eg, scabies could lead to rheumatic fever and nephropathy, as well as often debilitating physical, social, and mental effects that may deprive one of educational and social opportunities) [10,11].”
BackgroundMacPherson, P., Houben, R. M., Glynn, J. R., Corbett, E. L., & Kranzer, K. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.124800 · Cited by 230 · cited 1×
“” Losses in follow-up rates in LMICs, especially in sub-Saharan Africa, for any condition are known to be high due to multiple factors [37-39].”
Background
Research works printed but not linked: 4
- Mars, M, 2016, Stud Health Technol Inform, 231, 82
- 10.5334/ujia.ij · doi:10.5334/ujia.ij
- 10.1080/10447310802205776 · DOI · Paper page
- Saruro, J, 2011, A Practical Guide to the System Usability Scale: Background, Benchmarks and Best Practices
Cited by
Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: A pilot study
Yotsu, R. R., Ding, Z., Hamm, J., & Blanton, R. E. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011230 · Cited by 61
Self-citationDiagnosing skin neglected tropical diseases with the aid of digital health tools: A scoping review
Barnowska, E. J., Fastenau, A., Penna, S., Bonkass, A.-K., Stuetzle, S., & Janssen, R. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000629 · Cited by 20
“Two studies reported on five or more skin NTDs; one study [28] included buruli ulcer, leprosy, lymphatic filariasis, scabies, and yaws, while another study additionally included cutaneous leishmaniasis, mycetoma, onchocerciasis, and podoconiosis [29].”
BackgroundMethodInfluentialKamgno, J., Adeleke, M., Basáñez, M.-G., Coulibaly, Y. I., de Souza, D. K., Debrah, L. B., Debrah, A. Y., Diggle, P. J., Nana-Djeunga, H. C., Domché, A., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00084-2 · Cited by 16
Quilter, E. E. V., Butlin, C. R., Carrión, C., & Ruiz-Postigo, J.-A. (2024) · Leprosy Review · doi:10.47276/lr.95.2.2024030 · Cited by 13
Yotsu, R. R., Simmonds, R. E., de Souza, D. K., Phillips, R. O., Amoako, Y. A., Srivastava, S., Asiedu, K. B., Eyangoh, S. I., Johnson, P. D. R., & Pluschke, G. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00672-9 · Cited by 6
“The eSkinHealth app, a tele-dermatology platform implemented in West Africa, facilitates clinical documentation and supports diagnosis and management of patients with Buruli ulcer 244 .”
Self-citationMoungui, H. C., Iyawa, P. T., Nana-Djeunga, H. C., Ruiz-Postigo, J. A., & Carrión, C. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013461 · Cited by 5
“For example, a recent study to evaluate the usability and effectiveness of the eSkinHealth app for detecting and managing skin diseases in rural Côte d’Ivoire used the SUS tool [16].”
Telemedicine in the Clinical Care of Neglected Tropical Diseases: A Scoping Review
Salvador, F. G. F., Wakimoto, M. D., Duarte, C. C. J., Lapão, L. V., Silveira, H., & Valete, C. M. (2025) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0012431 · Cited by 4
“Consultations between remote people and healthcare provider - real-time/synchronous telemedicine 3 [18], [19,20] Transmission of medical data (e.g. images, notes) mediated by distant healthcare providers - asynchronous telemedicine 5 [14],[15–17”
InfluentialMobile Health and Telemedicine for Tropical Diseases
Ogwu, M. C., & Izah, S. C. (2025) · Health information science · doi:10.1007/978-3-031-82622-1_8 · Cited by 4
dos Santos, W. F. (2025) · Revista Pleiade · doi:10.32915/pleiade.v19i46.1143 · Cited by 3
Implementation of a marketing plan for the dissemination of the WHO SkinNTDs app in Cameroon
Moungui, H. C., Iyawa, P. T., Nana-Djeunga, H. C., Ruiz-Postigo, J. A., & Carrión, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333295 · Cited by 3
“◦ Opportunities: There is global momentum for sNTD elimination [1,22] and synergies with tele dermatology apps (e.g., eSkinHealth [37]).”
Siregar, G. O., Harianja, M., Smith, D. J., Ataupah, M. R., Laiskodat, R. D., Bøgh, C., Soebono, H., & Grijsen, M. L. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101739 · Cited by 3
“10,11 Leveraging existing microscopy infrastructure can enhance the detection of certain common and neglected skin diseases.”
The role of biosimilars in enhancing global access to psoriasis treatment
Behlock, Y., Gavan, S. P., Graier, T., Guevara, B. E. K., He, J., Giles, R. H., Wright, A. K., Ashcroft, D. M., Lim, H. W., de la Cruz, C., et al. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.01.047 · Cited by 2
Kuntal, K. (2026) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trag017 · Cited by 1
Teledermatology: The Most Recent Advancements and Applications of Mobile Apps: A Narrative Review
Molaalinejad, F., Eghdampour, F., menati, L., Qaderi, K., & Shamsabadi, A. (2026) · Health Science Reports · doi:10.1002/hsr2.72521 · Cited by 2
“Most reviewed studies under-score the role of mHealth as a facilitator in enhancing communication between patients and healthcare providers and in increasing patient access to specialists and practitioners, particularly in underserved regions [23].”
InfluentialJMIR Dermatology’s 2023 Year in Review
Rodriguez, R., & Dellavalle, R. P. (2024) · JMIR Dermatology · doi:10.2196/57007 · Cited by 1
“Yotsu et al [5] exemplified studies exploring the use of phone apps in rural, underserved communities; they evaluated how teledermatology can diagnose skin-related neglected tropical diseases.”
BackgroundAI in dermatology for low-income countries: addressing challenges and bridging gaps
Kakish, D. R. K., AlSamhori, J. F., & Nashwan, A. J. (2025) · Ethics Medicine and Public Health · doi:10.1016/j.jemep.2025.101049
Mobile Health Solutions for Accessibility
Mutha, S., Verma, A., Sharma, A., Sharma, A. M., Singh, P. K., & Sharma, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898811594125010004
Mwangi, L. W. (2024) · Theseus (Ammattikorkeakoulujen)
Yao, A., Almamy, D., Akanbi, S. M., Koffi, A. S., Nanan, V., Kouadio, K. L., Itoh, S., Kernizan, F., Schwinn, A. R., Dizoé, L. A. S., et al. (2026) · medRxiv · doi:10.64898/2026.05.11.26352967
Self-citationMinyilu, Y., Yimer, M. A., & Meshesha, M. (2026) · Online Journal of Public Health Informatics · doi:10.2196/84966
“Furthermore, recent studies such as [6,10] suggested the feasibility of mobile-based diagnostic platforms for resource-limited settings.”
Metadata
- Authors
- Yotsu, R. R., Almamy, D., Vagamon, B., Ugai, K., Itoh, S., Koffi, Y. D., Kaloga, M., Dizoé, L. A. S., Kouadio, K., Aka, N., Yeboue, L. K. G., Yao, K. A., & Blanton, R. E.
- Affiliations
- Tulane University (US)
- Université Alassane Ouattara (CI)
- Nagasaki University (JP)
- Tokyo Medical and Dental University (JP)
- Institut Pasteur de Côte d'Ivoire (CI)
- Corresponding author
- Yotsu, Rie R
- ORCID
- Venue
- JMIR Dermatology
- Publisher
- JMIR Publications Inc.
- Published
- 2023-06-14
- Volume
- 6
- Pages
- e46295
- ISSN
- 2562-0959 (ISSN-L)
- PMC
- PMC10335127
- OpenAlex
- W4382175410
- Semantic Scholar
- 4c6d4ee69191dcf4e99e1418e7c73cab36776b58
- Cited by
- 18
- References
- 45
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 1
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- JMIR Dermatology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Agency for Medical Research and Development (21jm0510004h0004)
- National Institutes of Health
- Fogarty International Center (R21TW011860, R33TW011860)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Physical Sciences › Computer Science › Information Systems › ICT in Developing Communities
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Keywords
- mobile health apps, skin diseases, neglected tropical diseases, teledermatology, Buruli ulcer, leprosy, lymphatic filariasis, scabies, yaws, community health workers, rural health care, resource-limited settings, app usability, skin disease detection, Côte d'Ivoire, sub-Saharan Africa, health worker empowerment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

